Journal ArticleUrologic oncology · June 2023
PurposeRenal function outcomes between radical nephroureterectomy (RNU) and nephron-sparing surgery (NSS) for upper tract urothelial carcinoma (UTUC) patients are not well established. We sought to compare the incidence and factors associated with ...
Full textCite
Journal ArticleUrol Oncol · August 2021
PURPOSE: Intravesical Bacillus Calmette-Guérin (BCG) is the gold standard for intermediate and high-risk non-muscle invasive bladder cancer (NMIBC), but availability is limited by global shortages. We present the first North American clinical experience us ...
Full textOpen AccessLink to itemCite
Journal ArticleWorld J Urol · May 2021
OBJECTIVES: To evaluate three subtypes of continent-cutaneous urinary diversion (CCUD); Indiana pouch (IP), right colon pouch with appendico-umbilicostomy (AU), and right colon pouch with neo-appendico-umbilicostomy (NAU), by investigating diversion-specif ...
Full textLink to itemCite
Journal ArticleSociété Internationale d’Urologie Journal · October 13, 2020
A “biomarker” is any measurable characteristic that indicates the presence or absence of disease or the biological response to a stimulus, typically an exposure or intervention. The FDA-NIH Biomarker Working Group has produced a document called Bio ...
Full textCite
Journal ArticleUrol Oncol · September 2020
BACKGROUND AND AIMS: The incidence of frailty is increasing as the population ages, which has important clinical implications given the associations between frailty and poor outcomes in the bladder cancer population. Due to a multi-organ system decline and ...
Full textOpen AccessLink to itemCite
Journal ArticleEur Urol Focus · July 15, 2020
GemRIS, an implantable drug delivery system from Taris Biomedical that delivers continuous intravesical gemcitabine, shows potential for use in multiple bladder cancer settings. Ongoing and recently completed phase 1 trials in non-muscle-invasive as well a ...
Full textOpen AccessLink to itemCite
Journal ArticleBladder Cancer · 2020
BACKGROUND: Nearly 70% of all new cases of bladder cancer are non-muscle invasive disease, the treatment for which includes transurethral resection followed by intravesical therapy. Unfortunately, recurrence rates approach 50% in part due to poor intravesi ...
Full textOpen AccessLink to itemCite
Journal ArticleUrol Oncol · September 2019
PURPOSE: To characterize drivers of ICU admission during index hospitalization after Radical Cystectomy (RC) with Enhanced Recovery After Surgery (ERAS) protocol, as well as corresponding outcomes. METHODS: A retrospective review of an IRB-approved cystect ...
Full textLink to itemCite
Journal ArticleCurr Opin Urol · January 2019
PURPOSE OF REVIEW: Management of extraretroperitoneal (ERP) germ cell tumor (GCT) is a complex clinical scenario faced by urologic oncologists. This article reviews the indications and approach to management of ERP GCT masses. RECENT FINDINGS: ERP GCT mana ...
Full textLink to itemCite
Journal ArticleJ Urol · October 2018
PURPOSE: We sought to develop and validate automated performance metrics to measure surgeon performance of vesicourethral anastomosis during robotic assisted radical prostatectomy. Furthermore, we sought to methodically develop a standardized training tuto ...
Full textLink to itemCite
Journal ArticleJ Urol · February 2018
PURPOSE: Tremendous interest and need lie at the intersection of telemedicine and minimally invasive surgery. Robotics provides an ideal environment for surgical telementoring and telesurgery given its endoscopic optics and mechanized instrument movement. ...
Full textLink to itemCite